A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...

Thanks to our generous supporters, Fred Hutch is redefining cancer and infectious disease for the next generation. Join us as we look beyond what’s possible today toward a new era of world-changing ...

The Pacific Northwest (PNW) Prostate Cancer SPORE aims to focus on finding molecular and other factors associated with the risk of prostate cancer recurrence and progression as well as its response – ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

After the emotional shock of a breast cancer recurrence, Teah decided to seek care – and proton therapy – at Fred Hutch ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

Proton therapy is an advanced radiation treatment that precisely targets tumors with a goal of limiting harm to healthy tissue. It may help reduce short- and long-term side effects, lower the risk of ...

Vaccine and Infectious Disease Division scientists pursue vaccines and therapies for infectious disease such as HIV through integrated and collaborative research and clinical care.

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been awarded a total of $7,268,202 from the Kuni Foundation’s Discovery Grant ...

The Biostatistics, Bioinformatics and Epidemiology Program (BBE) supplies the statistical and mathematical modeling expertise needed within Fred Hutch’s Vaccine and Infectious Disease Division to ...